celastrol has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fan, J; He, Y; Ren, M; Wang, H | 1 |
| Jia, D; Li, X; Wu, N; Zou, L | 1 |
| Anamalai, M; Deshmukh, S; Kaushal, S; Mishra, R; Patel, J; Sharma, S; Simpson, D; Singh, IS; Walker, BL; Zampino, M | 1 |
3 other study(ies) available for celastrol and Myocardial Infarction
| Article | Year |
|---|---|
Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats.
Topics: Animals; Fibrosis; Inflammasomes; Interleukin-18; Male; Molecular Docking Simulation; Myocardial Infarction; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley | 2023 |
Protective effect of celastrol on myocardial ischemia-reperfusion injury.
Topics: Cardiotonic Agents; Drugs, Chinese Herbal; Humans; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pentacyclic Triterpenes; Tripterygium; Triterpenes | 2017 |
Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.
Topics: Animals; Apoptosis; Cardiomyopathies; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Doxorubicin; GATA4 Transcription Factor; Gene Expression; Heat Shock Transcription Factors; Heat-Shock Proteins; Humans; Interleukin-1beta; Interleukin-6; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pentacyclic Triterpenes; Thioacetamide; Transcription Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |